Tag: fCALturbo

New Health Canada License for BÜHLMANN fCAL® turbo

BÜHLMANN fCAL® turbo Speed, Quality and Flexibility in Calprotectin Quantification BUHLMANN Diagnostics Corp (BDC), BÜHLMANN Laboratories AG’s North American affiliate is proud to announce that its innovative product, BÜHLMANN fCAL® turbo, has received a Medical Device License from Health Canada and is now commercially available in Canada.  The device was approved as a Class 2
Continue Reading

Random Access Immuno Turbidimetric Faecal Calprotectin Assay

In autumn 2015 BÜHLMANN will launch a new generation of faecal calprotectin assay. The BÜHLMANN fCAL™turbo, the next step in automation of faecal calprotectin quantification used for Research Use Only. Fecal calprotectin (fCAL) is the most important marker in the study of gut inflammation. fCAL testing today demands for a raised level of lab resources including

Continue Reading
Sign Up for BUHLMANN Updates!

Enter your email and stay on top of things,